Hangzhou Polymed Biopharmaceuticals
PrivateLast Round
VC Round
Dec 12, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hangzhou Polymed Biopharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of novel therapies for oncology and autoimmune diseases using protein degradation technologies and small molecule inhibitors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Polymed Biopharmaceuticals Comparables
Compare Hangzhou Polymed Biopharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gyre Therapeutics, Inc. | 77% | |
| C4 Therapeutics | 75% | |
| Arvinas Inc | 74% | |
Hangzhou Polymed Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 12, 2022 | ||||
| VC Round | Jul 30, 2021 |
Hangzhou Polymed Biopharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cybernaut Investment Group | VC Round |
| ZJKF Capital Management | VC Round |
| MPC | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 117% MoM, reaching 3.1K.
- May 1, 2026
Grew 75% QoQ from 4 to 7 employees.
Hangzhou Polymed Biopharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hangzhou Polymed Biopharmaceuticals's valuation, stock price, and market status.